{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:35:12Z","timestamp":1791326112187,"version":"4.3.1"},"reference-count":123,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.hoc.2022.06.009","type":"journal-article","created":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T22:16:13Z","timestamp":1668550573000},"page":"1151-1165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Chronic Pain"],"prefix":"10.1016","volume":"36","author":[{"given":"Christopher P.","family":"Carroll","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda M.","family":"Brandow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.hoc.2022.06.009_bib1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/1099800409337154","article-title":"Can heterogeneity of chronic sickle-cell disease pain be explained by genomics? A literature review","volume":"11","author":"Adegbola","year":"2009","journal-title":"Biol Res Nurs"},{"issue":"6","key":"10.1016\/j.hoc.2022.06.009_bib2","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jpainsymman.2011.06.020","article-title":"Detecting the emergence of chronic pain in sickle cell disease","volume":"43","author":"Hollins","year":"2012","journal-title":"J\u00a0Pain Symptom Manage"},{"issue":"2","key":"10.1016\/j.hoc.2022.06.009_bib3","doi-asserted-by":"crossref","first-page":"94","DOI":"10.7326\/0003-4819-148-2-200801150-00004","article-title":"Daily assessment of pain in adults with sickle cell disease","volume":"148","author":"Smith","year":"2008","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.hoc.2022.06.009_bib4","article-title":"AAPT Diagnostic Criteria for Chronic Sickle Cell Disease Pain","volume":"18","author":"Dampier","year":"2017","journal-title":"J\u00a0Pain"},{"issue":"Suppl 1","key":"10.1016\/j.hoc.2022.06.009_bib5","article-title":"Characteristics of a Chronic Pain Phenotype in Adults with Sickle Cell Disease","volume":"130","author":"Taylor","year":"2017","journal-title":"Blood"},{"issue":"1\u20132","key":"10.1016\/j.hoc.2022.06.009_bib6","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.pain.2009.06.029","article-title":"Pain site frequency and location in sickle cell disease: the PiSCES project","volume":"145","author":"McClish","year":"2009","journal-title":"Pain"},{"issue":"9","key":"10.1016\/j.hoc.2022.06.009_bib7","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1111\/j.1526-4610.2010.01763.x","article-title":"Individual differences in the subjective experience of pain: new insights into mechanisms and models","volume":"50","author":"Coghill","year":"2010","journal-title":"Headache"},{"issue":"12","key":"10.1016\/j.hoc.2022.06.009_bib8","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1182\/blood-2010-12-327429","article-title":"Transient receptor potential vanilloid 1 mediates pain in mice with severe sickle cell disease","volume":"118","author":"Hillery","year":"2011","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.hoc.2022.06.009_bib9","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1016\/j.pain.2014.05.030","article-title":"Cold hypersensitivity increases with age in mice with sickle cell disease","volume":"155","author":"Zappia","year":"2014","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.hoc.2022.06.009_bib10","first-page":"62","article-title":"Sickle cell mice exhibit mechanical allodynia and enhanced responsiveness in light touch cutaneous mechanoreceptors","volume":"8","author":"Garrison","year":"2012","journal-title":"Mol Pain"},{"key":"10.1016\/j.hoc.2022.06.009_bib11","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1182\/asheducation-2010.1.403","article-title":"Neurobiological mechanisms of pain in sickle cell disease","volume":"2010","author":"Wang","year":"2010","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"1","key":"10.1016\/j.hoc.2022.06.009_bib12","first-page":"4","article-title":"Endothelin receptors and pain","volume":"10","author":"Khodorova","year":"2009","journal-title":"J\u00a0Pain"},{"key":"10.1016\/j.hoc.2022.06.009_bib13","article-title":"An evaluation of central sensitization in patients with sickle cell disease","author":"Campbell","year":"2016","journal-title":"J\u00a0Pain"},{"issue":"4","key":"10.1016\/j.hoc.2022.06.009_bib14","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/bjh.15169","article-title":"Pain and opioid use after reversal of sickle cell disease following HLA-matched sibling haematopoietic stem cell transplant","volume":"184","author":"Darbari","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.hoc.2022.06.009_bib15","doi-asserted-by":"crossref","DOI":"10.1093\/pm\/pnaa464","article-title":"Pain experiences of adults with sickle cell disease and hematopoietic stem cell transplantation: a qualitative study","author":"Abu Al Hamayel","year":"2021","journal-title":"Pain Med"},{"issue":"0","key":"10.1016\/j.hoc.2022.06.009_bib16","article-title":"Chronic pain persists in adults with sickle cell disease despite regular red cell transfusions","volume":"0","author":"Karafin","year":"2019","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.hoc.2022.06.009_bib17","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.neulet.2019.04.013","article-title":"Sensitization of nociceptors and dorsal horn neurons contributes to pain in sickle cell disease","volume":"705","author":"Uhelski","year":"2019","journal-title":"Neurosci Lett"},{"issue":"9","key":"10.1016\/j.hoc.2022.06.009_bib18","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1097\/j.pain.0000000000000966","article-title":"Sensitization of C-fiber nociceptors in mice with sickle cell disease is decreased by local inhibition of anandamide hydrolysis","volume":"158","author":"Uhelski","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.hoc.2022.06.009_bib19","article-title":"Sensitization of nociceptors by prostaglandin E2-glycerol contributes to hyperalgesia in mice with sickle cell disease","volume":"22","author":"Khasabova","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2022.06.009_bib20","article-title":"Peripheral nerve pathology in sickle cell disease mice","volume":"1","author":"Sadler","year":"2019","journal-title":"PAIN Reports"},{"issue":"1","key":"10.1016\/j.hoc.2022.06.009_bib21","doi-asserted-by":"crossref","DOI":"10.1177\/1535370214544275","article-title":"Sickle cell disease in mice is associated with sensitization of sensory nerve fibers","volume":"240","author":"Kenyon","year":"2015","journal-title":"Exp Biol Med"},{"issue":"4","key":"10.1016\/j.hoc.2022.06.009_bib22","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/j.pain.0000000000000104","article-title":"Sensitization of nociceptive spinal neurons contributes to pain in a transgenic model of sickle cell disease","volume":"156","author":"Cataldo","year":"2015","journal-title":"Pain"},{"key":"10.1016\/j.hoc.2022.06.009_bib23","article-title":"Reduced glutamate channel phosphorylation in pain-related brain areas in a transgenic model of sickle cell disease","author":"LeBlanc","year":"2017","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.hoc.2022.06.009_bib24","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-2141.2011.08977.x","article-title":"Mouse models for studying pain in sickle disease: effects of strain, age, and acuteness","volume":"156","author":"Cain","year":"2012","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.hoc.2022.06.009_bib25","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1182\/blood-2010-01-260372","article-title":"Pain-related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: modulation by cannabinoids","volume":"116","author":"Kohli","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2022.06.009_bib26","doi-asserted-by":"crossref","DOI":"10.1007\/s40271-016-0166-z","article-title":"Cognitive testing of an electronic version of the faces pain scale-revised with pediatric and adolescent sickle cell patients","author":"Gupta","year":"2016","journal-title":"Patient"},{"issue":"7","key":"10.1016\/j.hoc.2022.06.009_bib27","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2017.187013","article-title":"Endothelin type a receptors mediate pain in a mouse model of sickle cell disease","volume":"103","author":"Lutz","year":"2018","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.hoc.2022.06.009_bib28","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2015.128736","article-title":"Small-molecule nociceptin receptor agonist ameliorates mast cell activation and pain in sickle mice","volume":"100","author":"Vang","year":"2015","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.hoc.2022.06.009_bib29","article-title":"An Evaluation of Central Sensitization in Patients with Sickle Cell Disease","volume":"17","author":"Campbell","year":"2016","journal-title":"J\u00a0Pain"},{"issue":"1","key":"10.1016\/j.hoc.2022.06.009_bib30","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/ajh.23341","article-title":"Patients with sickle cell disease have increased sensitivity to cold and heat","volume":"88","author":"Brandow","year":"2013","journal-title":"Am J Hematol"},{"key":"10.1016\/j.hoc.2022.06.009_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nicl.2016.12.024","article-title":"Characterization of functional brain activity and connectivity using EEG and fMRI in patients with sickle cell disease","volume":"14","author":"Case","year":"2017","journal-title":"NeuroImage: Clin"},{"issue":"11","key":"10.1016\/j.hoc.2022.06.009_bib32","first-page":"1077","article-title":"Frequency of Hospitalizations for Pain and Association With Altered Brain Network Connectivity in Sickle Cell Disease","volume":"16","author":"Darbari","year":"2015","journal-title":"J\u00a0Pain"},{"issue":"12","key":"10.1016\/j.hoc.2022.06.009_bib33","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1097\/AJP.0000000000000492","article-title":"Altered functional connectivity in sickle cell disease exists at rest and during acute pain challenge","volume":"33","author":"Zempsky","year":"2017","journal-title":"Clin J Pain"},{"issue":"21","key":"10.1016\/j.hoc.2022.06.009_bib34","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V124.21.2701.2701","article-title":"Resting State Neural Network Properties in Sickle Cell Disease Patients","volume":"124","author":"Zhang","year":"2014","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hoc.2022.06.009_bib35","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/j.amepre.2016.02.012","article-title":"Chronic Opioid Therapy and Central Sensitization in Sickle Cell Disease","volume":"51","author":"Carroll","year":"2016","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.hoc.2022.06.009_bib36","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1182\/bloodadvances.2018024299","article-title":"Effect of chronic opioid therapy on pain and survival in a humanized mouse model of sickle cell disease","volume":"3","author":"Tran","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.hoc.2022.06.009_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/ejp.1243","article-title":"Development and course of chronic pain over 4 years in the general population: The HUNT pain study","author":"Landmark","year":"2018","journal-title":"Eur J Pain"},{"issue":"5","key":"10.1016\/j.hoc.2022.06.009_bib38","first-page":"443","article-title":"Situational versus dispositional measurement of catastrophizing: associations with pain responses in multiple samples","volume":"11","author":"Campbell","year":"2010","journal-title":"J\u00a0Pain"},{"issue":"13","key":"10.1016\/j.hoc.2022.06.009_bib39","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/jama.2010.344","article-title":"Will This Patient Develop Persistent Disabling Low Back Pain?","volume":"303","author":"Chou","year":"2010","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.hoc.2022.06.009_bib40","doi-asserted-by":"crossref","DOI":"10.1097\/AJP.0000000000000827","article-title":"Changes in pain and psychosocial functioning and transition to chronic pain in pediatric sickle cell disease: a cohort follow-up study","volume":"36","author":"Sil","year":"2020","journal-title":"Clin J Pain"},{"issue":"3","key":"10.1016\/j.hoc.2022.06.009_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27538","article-title":"Pediatric pain screening identifies youth at risk of chronic pain in sickle cell disease","volume":"66","author":"Sil","year":"2019","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"10.1016\/j.hoc.2022.06.009_bib42","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/AJP.0000000000000289","article-title":"Psychosocial and functional outcomes in youth with chronic sickle cell pain","volume":"32","author":"Sil","year":"2016","journal-title":"Clin J Pain"},{"issue":"2","key":"10.1016\/j.hoc.2022.06.009_bib43","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1017\/S0033291703001041","article-title":"Depressive disorder as a long-term antecedent risk factor for incident back pain: a 13-year follow-up study from the Baltimore Epidemiological Catchment Area sample","volume":"34","author":"Larson","year":"2004","journal-title":"Psychol Med"},{"issue":"1","key":"10.1016\/j.hoc.2022.06.009_bib44","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jpsychores.2014.10.011","article-title":"Longitudinal association between pain, and depression and anxiety over four years","volume":"78","author":"Gerrits","year":"2015","journal-title":"J\u00a0Psychosomatic Res"},{"issue":"9","key":"10.1016\/j.hoc.2022.06.009_bib45","first-page":"964","article-title":"Reciprocal relationship between pain and depression: a 12-month longitudinal analysis in primary care","volume":"12","author":"Kroenke","year":"2011","journal-title":"J\u00a0pain : official J Am Pain Soc"},{"issue":"1","key":"10.1016\/j.hoc.2022.06.009_bib46","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/24740527.2017.1325715","article-title":"Predicting treatment outcomes of pain patients attending tertiary multidisciplinary pain treatment centers: A pain trajectory approach","volume":"1","author":"Pag\u00e9","year":"2017","journal-title":"Can J Pain"},{"issue":"9","key":"10.1016\/j.hoc.2022.06.009_bib47","first-page":"844","article-title":"Symptoms of depression are associated with opioid use regardless of pain severity and physical functioning among treatment-seeking patients with chronic pain","volume":"16","author":"Goesling","year":"2015","journal-title":"J\u00a0pain : official J Am Pain Soc"},{"issue":"1","key":"10.1016\/j.hoc.2022.06.009_bib48","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/j.pain.0000000000000730","article-title":"Incident and long-term opioid therapy among patients with psychiatric conditions and medications: a national study of commercial health care claims","volume":"158","author":"Quinn","year":"2017","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.hoc.2022.06.009_bib49","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/AJP.0b013e3180330dc5","article-title":"Psychiatric History and Psychologic Adjustment as Risk Factors for Aberrant Drug-related Behavior Among Patients With Chronic Pain","volume":"23","author":"Wasan","year":"2007","journal-title":"Clin J Pain"},{"issue":"2","key":"10.1016\/j.hoc.2022.06.009_bib50","first-page":"131","article-title":"Opioids for chronic noncancer pain: prediction and identification of aberrant drug-related behaviors: a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline","volume":"10","author":"Chou","year":"2009","journal-title":"J\u00a0pain : official J Am Pain Soc"},{"issue":"2","key":"10.1016\/j.hoc.2022.06.009_bib51","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/j.pain.0000000000000763","article-title":"New-onset depression following stable, slow, and rapid rate of prescription opioid dose escalation","volume":"158","author":"Salas","year":"2017","journal-title":"PAIN"},{"issue":"20","key":"10.1016\/j.hoc.2022.06.009_bib52","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1001\/jama.2009.723","article-title":"Optimized antidepressant therapy and pain self-management in primary care patients with depression and musculoskeletal pain: a randomized controlled trial","volume":"301","author":"Kroenke","year":"2009","journal-title":"JAMA : J Am Med Assoc"},{"issue":"8","key":"10.1016\/j.hoc.2022.06.009_bib53","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1097\/PSY.0b013e318185c510","article-title":"Association of depression and anxiety alone and in combination with chronic musculoskeletal pain in primary care patients","volume":"70","author":"Bair","year":"2008","journal-title":"Psychosom Med"},{"issue":"1","key":"10.1016\/j.hoc.2022.06.009_bib54","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/01.PSY.0000106883.94059.C5","article-title":"Impact of pain on depression treatment response in primary care","volume":"66","author":"Bair","year":"2004","journal-title":"Psychosom Med"},{"issue":"18","key":"10.1016\/j.hoc.2022.06.009_bib55","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1001\/jama.290.18.2428","article-title":"Effect of improving depression care on pain and functional outcomes among older adults with arthritis: a randomized controlled trial","volume":"290","author":"Lin","year":"2003","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.hoc.2022.06.009_bib56","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/AJP.0b013e3182579935","article-title":"Opioid cessation and multidimensional outcomes after interdisciplinary chronic pain treatment","volume":"29","author":"Murphy","year":"2013","journal-title":"Clin J Pain"},{"issue":"1\u20132","key":"10.1016\/j.hoc.2022.06.009_bib57","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.pain.2004.09.012","article-title":"Core outcome measures for chronic pain clinical trials: IMMPACT recommendations","volume":"113","author":"Dworkin","year":"2005","journal-title":"Pain"},{"issue":"7","key":"10.1016\/j.hoc.2022.06.009_bib58","doi-asserted-by":"crossref","first-page":"492","DOI":"10.7326\/0003-4819-147-7-200710020-00007","article-title":"Nonpharmacologic therapies for acute and chronic low back pain: a review of the evidence for an American Pain Society\/American College of Physicians clinical practice guideline","volume":"147","author":"Chou","year":"2007","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.hoc.2022.06.009_bib59","doi-asserted-by":"crossref","DOI":"10.7326\/M14-2559","article-title":"The effectiveness and risks of long-term opioid therapy for chronic pain: A systematic review for a national institutes of health pathways to prevention workshop","volume":"162","author":"Chou","year":"2015","journal-title":"Ann Intern Med"},{"issue":"21","key":"10.1016\/j.hoc.2022.06.009_bib60","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1001\/jama.2017.18706","article-title":"Detection, Evaluation, and Management of High Blood Pressure in Adults","volume":"318","author":"Cifu","year":"2017","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.hoc.2022.06.009_bib61","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.pain.2010.11.002","article-title":"Acceptance-based interventions for the treatment of chronic pain: A systematic review and meta-analysis","volume":"152","author":"Veehof","year":"2011","journal-title":"PAIN"},{"issue":"3","key":"10.1016\/j.hoc.2022.06.009_bib62","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.pain.2004.09.008","article-title":"Acceptance of the unpleasant reality of chronic pain: effects upon attention to pain and engagement with daily activities","volume":"112","author":"Viane","year":"2004","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.hoc.2022.06.009_bib63","first-page":"408","article-title":"Acceptance, mindfulness, and values-based action may counteract fear and avoidance of emotions in chronic pain: an analysis of anxiety sensitivity","volume":"10","author":"McCracken","year":"2009","journal-title":"J\u00a0Pain"},{"issue":"3","key":"10.1016\/j.hoc.2022.06.009_bib64","first-page":"319","article-title":"Pain acceptance decouples the momentary associations between pain, pain interference, and physical activity in the daily lives of people with chronic pain and spinal cord injury","volume":"18","author":"Kratz","year":"2017","journal-title":"J\u00a0pain : official J Am Pain Soc"},{"issue":"6","key":"10.1016\/j.hoc.2022.06.009_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpainsymman.2016.12.351","article-title":"A\u00a0Randomized Trial of Yoga for Children Hospitalized With Sickle Cell Vaso-Occlusive Crisis","volume":"53","author":"Moody","year":"2017","journal-title":"J\u00a0Pain Symptom Manage"},{"issue":"12","key":"10.1016\/j.hoc.2022.06.009_bib66","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1182\/bloodadvances.2020001851","article-title":"American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain","volume":"4","author":"Brandow","year":"2020","journal-title":"Blood Adv"},{"issue":"10","key":"10.1016\/j.hoc.2022.06.009_bib67","doi-asserted-by":"crossref","DOI":"10.1007\/s11916-020-00898-0","article-title":"Low-Dose Naltrexone for Chronic Pain: Update and Systemic Review","volume":"24","author":"Kim","year":"2020","journal-title":"Curr Pain Headache Rep"},{"issue":"10","key":"10.1016\/j.hoc.2022.06.009_bib68","first-page":"770","article-title":"Efficacy and safety of low-dose naltrexone in painful diabetic neuropathy: A randomized, double-blind, active-control, crossover clinical trial","volume":"13","author":"Srinivasan","year":"2021","journal-title":"J\u00a0Diabetes"},{"issue":"10","key":"10.1016\/j.hoc.2022.06.009_bib69","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1177\/1049909119838974","article-title":"Pharmacology Update: Low-Dose Naltrexone as a Possible Nonopioid Modality for Some Chronic, Nonmalignant Pain Syndromes","volume":"36","author":"Trofimovitch","year":"2019","journal-title":"Am J Hosp Palliat Med"},{"issue":"3","key":"10.1016\/j.hoc.2022.06.009_bib70","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/phar.2086","article-title":"The Safety and Efficacy of Low-Dose Naltrexone in the Management of Chronic Pain and Inflammation in Multiple Sclerosis, Fibromyalgia, Crohn\u2019s Disease, and Other Chronic Pain Disorders","volume":"38","author":"Patten","year":"2018","journal-title":"Pharmacotherapy"},{"issue":"14","key":"10.1016\/j.hoc.2022.06.009_bib71","doi-asserted-by":"crossref","first-page":"E1652","DOI":"10.1212\/WNL.0000000000007238","article-title":"NMDA receptor antagonists and pain relief: A meta-analysis of experimental trials","volume":"92","author":"Thompson","year":"2019","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.hoc.2022.06.009_bib72","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1182\/bloodadvances.2019000940","article-title":"Bleeding in patients with sickle cell disease: A population-based study","volume":"4","author":"Hariharan","year":"2020","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.hoc.2022.06.009_bib73","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/ajh.23625","article-title":"Sickle-cell disease stroke throughout life: a retrospective study in an adult referral center","volume":"89","author":"Gueguen","year":"2014","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1016\/j.hoc.2022.06.009_bib74","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1586\/ehm.11.61","article-title":"The epidemiology, evaluation and treatment of stroke in adults with sickle cell disease","volume":"4","author":"Strouse","year":"2011","journal-title":"Expert Rev Hematol"},{"issue":"3","key":"10.1016\/j.hoc.2022.06.009_bib75","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0022-3476(05)82150-X","article-title":"High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell disease","volume":"118","author":"Wang","year":"1991","journal-title":"J\u00a0Pediatr"},{"issue":"Suppl 1","key":"10.1016\/j.hoc.2022.06.009_bib76","first-page":"SI53","article-title":"Renal effects of nonselective NSAIDs and coxibs","volume":"69","author":"Weir","year":"2002","journal-title":"Cleve Clin J Med"},{"issue":"25","key":"10.1016\/j.hoc.2022.06.009_bib77","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJM199412223312502","article-title":"Risk of Kidney Failure Associated with the Use of Acetaminophen, Aspirin, and Nonsteroidal Antiinflammatory Drugs","volume":"331","author":"Perneger","year":"1994","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.hoc.2022.06.009_bib78","doi-asserted-by":"crossref","first-page":"e187896","DOI":"10.1001\/jamanetworkopen.2018.7896","article-title":"Association of Nonsteroidal Anti-inflammatory Drug Prescriptions With Kidney Disease Among Active Young and Middle-aged Adults","volume":"2","author":"Nelson","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"11","key":"10.1016\/j.hoc.2022.06.009_bib79","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1001\/archinte.168.11.1219","article-title":"Cyclooxygenase Selectivity of Nonsteroidal Anti-inflammatory Drugs and Risk of Stroke","volume":"168","author":"Haag","year":"2008","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.hoc.2022.06.009_bib80","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2377-9-6","article-title":"Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain","volume":"9","author":"Quilici","year":"2009","journal-title":"BMC Neurol"},{"issue":"3","key":"10.1016\/j.hoc.2022.06.009_bib81","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.pain.2004.05.010","article-title":"Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study","volume":"110","author":"Rowbotham","year":"2004","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.hoc.2022.06.009_bib82","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1471-2474-15-76","article-title":"The efficacy of duloxetine, non-steroidal anti-inflammatory drugs, and opioids in osteoarthritis: a systematic literature review and meta-analysis","volume":"15","author":"Myers","year":"2014","journal-title":"BMC Musculoskelet Disord"},{"issue":"3","key":"10.1016\/j.hoc.2022.06.009_bib83","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.pain.2009.06.024","article-title":"Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: a 13-week, randomized, placebo-controlled trial","volume":"146","author":"Chappell","year":"2009","journal-title":"Pain"},{"issue":"7","key":"10.1016\/j.hoc.2022.06.009_bib84","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1111\/pme.12800","article-title":"Efficacy and Safety of Duloxetine on Osteoarthritis Knee Pain: A Meta-Analysis of Randomized Controlled Trials","volume":"16","author":"Wang","year":"2015","journal-title":"Pain Med"},{"issue":"14","key":"10.1016\/j.hoc.2022.06.009_bib85","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1200\/JCO.2004.08.141","article-title":"Gabapentin for neuropathic cancer pain: a randomized controlled trial from the Gabapentin Cancer Pain Study Group","volume":"22","author":"Caraceni","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.hoc.2022.06.009_bib86","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00131402-200112000-00002","article-title":"Gabapentin and venlafaxine for the treatment of painful diabetic neuropathy","volume":"3","author":"Simpson","year":"2001","journal-title":"J\u00a0Clin Neuromuscul Dis"},{"issue":"21","key":"10.1016\/j.hoc.2022.06.009_bib87","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1001\/jama.280.21.1837","article-title":"Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial","volume":"280","author":"Rowbotham","year":"1998","journal-title":"J\u00a0Am Med Assoc"},{"issue":"8","key":"10.1016\/j.hoc.2022.06.009_bib88","doi-asserted-by":"crossref","first-page":"e1002369","DOI":"10.1371\/journal.pmed.1002369","article-title":"Benefits and safety of gabapentinoids in chronic low back pain: A systematic review and meta-analysis of randomized controlled trials","volume":"14","author":"Shanthanna","year":"2017","journal-title":"PLOS Med"},{"issue":"10","key":"10.1016\/j.hoc.2022.06.009_bib89","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002396","article-title":"Gabapentin, opioids, and the risk of opioid-related death: A population-based nested case\u2013control study","volume":"14","author":"Gomes","year":"2017","journal-title":"PLoS Med"},{"issue":"2","key":"10.1016\/j.hoc.2022.06.009_bib90","first-page":"147","article-title":"Research gaps on use of opioids for chronic noncancer pain: findings from a review of the evidence for an American pain society and american academy of pain medicine clinical practice guideline","volume":"10","author":"Chou","year":"2009","journal-title":"J\u00a0Pain"},{"issue":"9","key":"10.1016\/j.hoc.2022.06.009_bib91","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1001\/jama.2018.0899","article-title":"Effect of opioid vs nonopioid medications on pain-related function in patients with chronic back pain or hip or knee osteoarthritis pain","volume":"319","author":"Krebs","year":"2018","journal-title":"JAMA"},{"issue":"09","key":"10.1016\/j.hoc.2022.06.009_bib92","doi-asserted-by":"crossref","first-page":"932","DOI":"10.4088\/JCP.13m08349","article-title":"National trends in the office-based prescription of schedule II opioids","volume":"74","author":"Olfson","year":"2013","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"4","key":"10.1016\/j.hoc.2022.06.009_bib93","first-page":"225","article-title":"Opioid Prescriptions by U.S. Primary Care Physicians From 1992 to 2001","volume":"7","author":"Olsen","year":"2006","journal-title":"J\u00a0Pain"},{"issue":"3","key":"10.1016\/j.hoc.2022.06.009_bib94","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/acem.12328","article-title":"Rising opioid prescribing in adult u.s. emergency department visits: 2001-2010","volume":"21","author":"Mazer-Amirshahi","year":"2014","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.hoc.2022.06.009_bib95","article-title":"Pain and opioid use after reversal of sickle cell disease following HLA-matched sibling haematopoietic stem cell transplant","author":"Darbari","year":"2018","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.hoc.2022.06.009_bib96","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1177\/082585970502100403","article-title":"Physicians\u2019 attitude and practices in sickle cell disease pain management","volume":"21","author":"Labbe","year":"2005","journal-title":"J\u00a0Palliat Care"},{"issue":"4","key":"10.1016\/j.hoc.2022.06.009_bib97","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1053\/apnr.2001.26783","article-title":"J.\u00a0Nurses\u2019 attitudes and practices in sickle cell pain management","volume":"14","author":"Pack-Mabien","year":"2001","journal-title":"Appl Nurs Res"},{"issue":"4","key":"10.1016\/j.hoc.2022.06.009_bib98","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.annemergmed.2013.02.004","article-title":"Emergency Provider Analgesic Practices and Attitudes Toward Patients With Sickle Cell Disease","volume":"62","author":"Glassberg","year":"2013","journal-title":"Ann Emerg Med"},{"issue":"2","key":"10.1016\/j.hoc.2022.06.009_bib99","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.pec.2009.01.007","article-title":"Health care provider attitudes toward patients with acute vaso-occlusive crisis due to sickle cell disease: development of a scale","volume":"76","author":"Ratanawongsa","year":"2009","journal-title":"Patient Educ Couns"},{"issue":"2","key":"10.1016\/j.hoc.2022.06.009_bib100","first-page":"89","article-title":"The Association of Clinician Characteristics with their Attitudes Toward Patients with Sickle Cell Disease: Secondary Analyses of a Randomized Controlled Trial","volume":"107","author":"Haywood","year":"2015","journal-title":"J\u00a0Natl Med Assoc"},{"issue":"6","key":"10.1016\/j.hoc.2022.06.009_bib101","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s11606-009-1247-7","article-title":"The association of provider communication with trust among adults with sickle cell disease","volume":"25","author":"Haywood","year":"2010","journal-title":"J\u00a0Gen Intern Med"},{"issue":"12","key":"10.1016\/j.hoc.2022.06.009_bib102","doi-asserted-by":"crossref","DOI":"10.1007\/s11606-014-2986-7","article-title":"Perceived Discrimination, Patient Trust, and Adherence to Medical Recommendations Among Persons with Sickle Cell Disease","volume":"29","author":"Haywood","year":"2014","journal-title":"J\u00a0Gen Intern Med"},{"issue":"5","key":"10.1016\/j.hoc.2022.06.009_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpainsymman.2014.02.002","article-title":"Perceived discrimination in health care is associated with a greater burden of pain in sickle cell disease","volume":"48","author":"Haywood","year":"2014","journal-title":"J\u00a0Pain Symptom Manage"},{"issue":"2","key":"10.1016\/j.hoc.2022.06.009_bib104","first-page":"113","article-title":"Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain","volume":"10","author":"Chou","year":"2009","journal-title":"J\u00a0pain"},{"issue":"4","key":"10.1016\/j.hoc.2022.06.009_bib105","doi-asserted-by":"crossref","first-page":"276","DOI":"10.7326\/M14-2559","article-title":"The Effectiveness and Risks of Long-Term Opioid Therapy for Chronic Pain: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop","volume":"162","author":"Chou","year":"2015","journal-title":"Ann Intern Med"},{"issue":"22","key":"10.1016\/j.hoc.2022.06.009_bib106","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1001\/jama.2016.7789","article-title":"Prescription of Long-Acting Opioids and Mortality in Patients With Chronic Noncancer Pain","volume":"315","author":"Ray","year":"2016","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.hoc.2022.06.009_bib107","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/AJP.0000000000000183","article-title":"Changes in coping, pain, and activity after cognitive-behavioral training: a randomized clinical trial for pediatric sickle cell disease using smartphones","volume":"31","author":"Schatz","year":"2015","journal-title":"Clin J Pain"},{"issue":"1","key":"10.1016\/j.hoc.2022.06.009_bib108","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1037\/0278-6133.19.1.85","article-title":"Follow-up of coping skills training in adults with sickle cell disease: analysis of daily pain and coping practice diaries","volume":"19","author":"Gil","year":"2000","journal-title":"Health Psychol"},{"issue":"1","key":"10.1016\/j.hoc.2022.06.009_bib109","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1037\/0278-6133.15.1.3","article-title":"Effects of cognitive coping skills training on coping strategies and experimental pain sensitivity in African American adults with sickle cell disease","volume":"15","author":"Gil","year":"1996","journal-title":"Health Psychol"},{"issue":"3","key":"10.1016\/j.hoc.2022.06.009_bib110","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/jpepsy\/26.3.163","article-title":"Daily coping practice predicts treatment effects in children with sickle cell disease","volume":"26","author":"Gil","year":"2001","journal-title":"J\u00a0Pediatr Psychol"},{"issue":"6","key":"10.1016\/j.hoc.2022.06.009_bib111","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.jpainsymman.2021.06.003","article-title":"Acupuncture as an adjunctive treatment for pain in hospitalized children with sickle cell disease","volume":"62","author":"Reece-Stremtan","year":"2021","journal-title":"J\u00a0Pain Symptom Manage"},{"issue":"9","key":"10.1016\/j.hoc.2022.06.009_bib112","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/AJP.0000000000000036","article-title":"A\u00a0retrospective review of acupuncture use for the treatment of pain in sickle cell disease patients: Descriptive analysis from a single institution","volume":"30","author":"Lu","year":"2014","journal-title":"Clin J Pain"},{"issue":"1","key":"10.1016\/j.hoc.2022.06.009_bib113","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/msc.1141","article-title":"Long-Term Outcomes of Multidisciplinary Rehabilitation for Chronic Musculoskeletal Pain","volume":"15","author":"Volker","year":"2017","journal-title":"Musculoskeletal Care"},{"key":"10.1016\/j.hoc.2022.06.009_bib114","doi-asserted-by":"crossref","first-page":"h444","DOI":"10.1136\/bmj.h444","article-title":"Multidisciplinary biopsychosocial rehabilitation for chronic low back pain: Cochrane systematic review and meta-analysis","volume":"350","author":"Kamper","year":"2015","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.hoc.2022.06.009_bib115","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/jhm.850","article-title":"Prediction of onset and course of high hospital utilization in sickle cell disease","volume":"6","author":"Carroll","year":"2011","journal-title":"J\u00a0Hosp Med official Publ Soc Hosp Med"},{"issue":"10","key":"10.1016\/j.hoc.2022.06.009_bib116","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/ajh.21515","article-title":"The course and correlates of high hospital utilization in sickle cell disease: Evidence from a large, urban Medicaid managed care organization","volume":"84","author":"Carroll","year":"2009","journal-title":"Am J Hematol"},{"issue":"13","key":"10.1016\/j.hoc.2022.06.009_bib117","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1001\/jama.2010.378","article-title":"Acute care utilization and rehospitalizations for sickle cell disease","volume":"303","author":"Brousseau","year":"2010","journal-title":"JAMA: J Am Med Assoc"},{"issue":"1","key":"10.1016\/j.hoc.2022.06.009_bib118","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJM199107043250103","article-title":"Pain in sickle cell disease. Rates and risk factors","volume":"325","author":"Platt","year":"1991","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.hoc.2022.06.009_bib119","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-2218","article-title":"Improving care for sickle cell pain crisis using a multidisciplinary approach","volume":"143","author":"Balsamo","year":"2019","journal-title":"Pediatrics"},{"issue":"Supplement 1","key":"10.1016\/j.hoc.2022.06.009_bib120","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1182\/blood-2018-99-111435","article-title":"Assessing the Safety and Efficacy of Converting Adults with Sickle Cell Disease from Full Agonist Opioids to Buprenorphine","volume":"132","author":"David","year":"2018","journal-title":"Blood"},{"issue":"Supplement_1","key":"10.1016\/j.hoc.2022.06.009_bib121","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1182\/blood-2019-126589","article-title":"Use of Buprenorphine\/Naloxone in Ameliorating Acute Care Utilization and Chronic Opioid Use in Adults with Sickle Cell Disease","volume":"134","author":"Osunkwo","year":"2019","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hoc.2022.06.009_bib122","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/j.pain.0000000000002331","volume":"163","author":"Farrar","year":"2022","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.hoc.2022.06.009_bib123","doi-asserted-by":"crossref","first-page":"181","DOI":"10.7326\/M17-0598","article-title":"Patient outcomes in dose reduction or discontinuation of long-term opioid therapy","volume":"167","author":"Frank","year":"2017","journal-title":"Ann Intern Med"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858822000673?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858822000673?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:19:30Z","timestamp":1760185170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858822000673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":123,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S0889858822000673"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2022.06.009","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic Pain","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2022.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}